6019 related articles for article (PubMed ID: 27486138)
1. Mendelian Randomization as an Approach to Assess Causality Using Observational Data.
Sekula P; Del Greco M F; Pattaro C; Köttgen A
J Am Soc Nephrol; 2016 Nov; 27(11):3253-3265. PubMed ID: 27486138
[TBL] [Abstract][Full Text] [Related]
2. [Mendelian randomization approach, used for causal inferences].
Wang LN; Zhang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):547-552. PubMed ID: 28468080
[TBL] [Abstract][Full Text] [Related]
3. Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders.
Bell KJL; Loy C; Cust AE; Teixeira-Pinto A
Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e005623. PubMed ID: 33397121
[TBL] [Abstract][Full Text] [Related]
4. [Challenges and factors that influencing causal inference and interpretation, based on Mendelian randomization studies].
Wang YZ; Shen HB
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1231-1236. PubMed ID: 32867428
[TBL] [Abstract][Full Text] [Related]
5. [Application of mendelian randomization methods in causal inference of observational study].
Lin LJ; Wei YY; Zhang RY; Chen F
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jun; 53(6):619-624. PubMed ID: 31177761
[TBL] [Abstract][Full Text] [Related]
6. From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.
Benn M; Nordestgaard BG
Cardiovasc Res; 2018 Jul; 114(9):1192-1208. PubMed ID: 29471399
[TBL] [Abstract][Full Text] [Related]
7. Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer.
Wade KH; Yarmolinsky J; Giovannucci E; Lewis SJ; Millwood IY; Munafò MR; Meddens F; Burrows K; Bell JA; Davies NM; Mariosa D; Kanerva N; Vincent EE; Smith-Byrne K; Guida F; Gunter MJ; Sanderson E; Dudbridge F; Burgess S; Cornelis MC; Richardson TG; Borges MC; Bowden J; Hemani G; Cho Y; Spiller W; Richmond RC; Carter AR; Langdon R; Lawlor DA; Walters RG; Vimaleswaran KS; Anderson A; Sandu MR; Tilling K; Davey Smith G; Martin RM; Relton CL;
Cancer Causes Control; 2022 May; 33(5):631-652. PubMed ID: 35274198
[TBL] [Abstract][Full Text] [Related]
8. Mendelian randomization for cardiovascular diseases: principles and applications.
Larsson SC; Butterworth AS; Burgess S
Eur Heart J; 2023 Dec; 44(47):4913-4924. PubMed ID: 37935836
[TBL] [Abstract][Full Text] [Related]
9. Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization.
Smith GD; Timpson N; Ebrahim S
Ann Med; 2008; 40(7):524-41. PubMed ID: 18608114
[TBL] [Abstract][Full Text] [Related]
10. Mendelian Randomization as a Tool for Cardiovascular Research: A Review.
Levin MG; Burgess S
JAMA Cardiol; 2024 Jan; 9(1):79-89. PubMed ID: 37938820
[TBL] [Abstract][Full Text] [Related]
11. Mendelian randomization as a tool for causal inference in human nutrition and metabolism.
Larsson SC
Curr Opin Lipidol; 2021 Feb; 32(1):1-8. PubMed ID: 33278081
[TBL] [Abstract][Full Text] [Related]
12. A review of instrumental variable estimators for Mendelian randomization.
Burgess S; Small DS; Thompson SG
Stat Methods Med Res; 2017 Oct; 26(5):2333-2355. PubMed ID: 26282889
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of Mendelian randomization studies on multiple sclerosis.
Fazia T; Baldrighi GN; Nova A; Bernardinelli L
Eur J Neurosci; 2023 Aug; 58(4):3172-3194. PubMed ID: 37463755
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.
Burgess S; Bowden J; Fall T; Ingelsson E; Thompson SG
Epidemiology; 2017 Jan; 28(1):30-42. PubMed ID: 27749700
[TBL] [Abstract][Full Text] [Related]
15. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
16. Genetic instrumental variable analysis: time to call mendelian randomization what it is. The example of alcohol and cardiovascular disease.
Mukamal KJ; Stampfer MJ; Rimm EB
Eur J Epidemiol; 2020 Feb; 35(2):93-97. PubMed ID: 31761964
[TBL] [Abstract][Full Text] [Related]
17. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.
Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR
Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.
He W; Castiblanco J; Walter EA; Okulicz JF; Ahuja SK
Curr Opin HIV AIDS; 2010 Nov; 5(6):545-59. PubMed ID: 20978399
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates.
Taylor AE; Davies NM; Ware JJ; VanderWeele T; Smith GD; Munafò MR
Econ Hum Biol; 2014 Mar; 13(100):99-106. PubMed ID: 24388127
[TBL] [Abstract][Full Text] [Related]
20. Inferring the direction of a causal link and estimating its effect via a Bayesian Mendelian randomization approach.
Bucur IG; Claassen T; Heskes T
Stat Methods Med Res; 2020 Apr; 29(4):1081-1111. PubMed ID: 31146640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
